High-strength cannabis linked to psychosis
New study says one in ten first-time psychotic disorders may be linked to strong drugs
People who use high-strength cannabis may be at increased risk of developing serious mental health issues, according to new research.
The study, outlined in a paper in The Lancet Psychiatry journal, found that an estimated one in ten new cases of psychosis may be associated with strong cannabis.
And “in London and Amsterdam, where most of the cannabis that is sold is very strong, the risk could be much more”, reports the BBC.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The researchers, who looked at data from 11 European cities and towns, estimated that 30% of first-time cases of psychotic disorders in London, and half of those in Amsterdam, could be avoided if high-potency cannabis was not available.
The findings back up those of other experts who “have previously flagged a link between cannabis use and psychosis, particularly among vulnerable people with heavy use of the drug”, says The Guardian.
“If you are a psychologist like me who works in this catchment area and sees first-episode psychosis patients, this has a significant impact at the level of services and, I would also argue, family and society,” said Dr Marta Di Forti, lead author of the new study, from King’s College London.
“If you decide to use high-potency cannabis bear in mind there is this potential risk,” she added.
High-strength cannabis, such as that known as “skunk”, has levels of the psychoactive substance tetrahydrocannabinol (THC) above 10%. According to data released last year, 94% of police cannabis seizures in the UK were of high-strength varieties.
The new study found that daily cannabis users in Amsterdam were seven times more likely to develop a psychotic disorder than people who had never used the drug. “Almost all cannabis sold in ‘coffee shops’ in Amsterdam is high-strength, while varieties with 67% THC have been found in the Netherlands,” notes The Guardian.
Study-co-author Professor Robin Murray said the research had implications for the debate on whether cannabis should be legalised.
“If you are going to legalise cannabis, unless you want to pay for more a lot more psychiatric beds and a lot more psychiatrists, then you need to devise a system where you would legalise in a way that wouldn’t increase the consumption and increase the potency,” he said.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Oysters from New York's past could shore up its future
Under the Radar Project aims to seed a billion oysters in the city's waterways to improve water quality, fight coastal erosion and protect against storm surges
By Harriet Marsden, The Week UK Published
-
Today's political cartoons - November 24, 2024
Cartoons Sunday's cartoons - taped bananas, flying monkeys, and more
By The Week US Published
-
The Spanish cop, 20 million euros and 13 tonnes of cocaine
In the Spotlight Óscar Sánchez Gil, Chief Inspector of Spain's Economic and Tax Crimes Unit, has been arrested for drug trafficking
By The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
Avatar therapy: a groundbreaking treatment for psychosis?
In the Spotlight Study reveals digital characters can help patients 'push back' against distressing voices
By Irenie Forshaw, The Week UK Published
-
4 tips for coping with election anxiety and stress
The Week Recommends Election news is hard to circumvent. But navigating the politically charged season does not have to be stressful.
By Theara Coleman, The Week US Published
-
The 'game-changing' treatment for schizophrenia
The Explainer US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects
By Harriet Marsden, The Week UK Published
-
How the brain changes during pregnancy
In The Spotlight 'Baby brain' has some scientific basis but not in the way we first thought
By Chas Newkey-Burden, The Week UK Published
-
Psychedelic drugs and treating mental illness
The Explainer Scientists claim hallucinogenics could help treat depression and anxiety, but not everyone is convinced
By Elizabeth Carr-Ellis, The Week UK Published
-
Young adults are in a mental health crisis. Why is little being done?
In the spotlight The kids are, in fact, not at all alright.
By Theara Coleman, The Week US Published
-
Neurocosmetics: the beauty trend blending mental health and skin care
The Explainer Could a moisturizer really shift your mood?
By Theara Coleman, The Week US Published